LASE Corp. filed a Form 10-Q with the SEC on November 12, 2026, covering the quarterly period ended September 30, 2026, reporting a net loss of $2,516,509 for the three months ended that date.

Key Highlights

  • Quarterly net loss: $2,516,509 for the three months ended September 30, 2026, compared to $4,655,608 in the same period of 2025, according to the filing.
  • Nine-month net loss: $8,565,051 for the nine months ended September 30, 2026, versus $8,110,233 for the same period of 2025.
  • Net sales: $1,145,676 for the three months ended September 30, 2026, up from $919,284 in the prior-year quarter; nine-month net sales were $3,867,534, down from $5,808,541.
  • Gross loss: $(449,247) for the three months ended September 30, 2026, and $(685,225) for the nine months ended September 30, 2026.
  • Total assets increased: $15,805,952 as of September 30, 2026, compared to $9,449,602 as of December 31, 2025, the filing disclosed.
  • Stockholders' equity turned positive: $5,827,038 at September 30, 2026, versus a deficit of $(5,036,586) at December 31, 2025.
  • Shares outstanding: 60,679,288 shares of common stock, par value $0.001, outstanding as of November 12, 2026.

LASE Corp. Financial Results for the Quarter Ended September 30, 2026

LASE Corp. (NASDAQ:LASE), formerly named Laser Photonics Corporation, filed its quarterly report covering the period ended September 30, 2026. According to the filing, net sales for the three months ended September 30, 2026 were $1,145,676, up from $919,284 in the same quarter of 2025. For the nine-month period, however, net sales declined to $3,867,534 from $5,808,541 in the prior-year period. Cost of sales exceeded net sales in both the three- and nine-month periods, resulting in gross losses of $(449,247) and $(685,225), respectively.

The filing reported total operating expenses of $1,840,594 for the three months ended September 30, 2026, compared to $2,783,719 in the same period of 2025. These included sales and marketing expenses of $495,259, general and administrative expenses of $1,092,112, and research and development costs of $253,223. The operating loss for the quarter was $(2,289,841), narrower than the $(3,217,315) reported in Q3 2025. For the nine months ended September 30, 2026, the operating loss was $(7,277,776) versus $(5,752,528) in the prior-year period.

On the balance sheet, the filing disclosed that total assets grew to $15,805,952 as of September 30, 2026, from $9,449,602 as of December 31, 2025. This increase was driven in part by $6,000,000 in short-term investments and cash of $1,638,650 at quarter-end, compared to $650,339 in cash at December 31, 2025. Notes payable, which totaled $3,804,610 at December 31, 2025, were reported as $0 at September 30, 2026. The accumulated deficit stood at $(33,775,410) at September 30, 2026, compared to $(25,210,359) at December 31, 2025. Common shares issued increased to 60,686,666 from 22,852,723 over the same period, the filing stated.

What Was Disclosed

LASE Corp. disclosed its unaudited condensed consolidated financial statements for the quarter and nine months ended September 30, 2026, including the balance sheet, income statement, and partial cash flow statement, filed on November 12, 2026.